- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05187351
Native Coronary Artery Instead of SAphenous Vein Graft Intervention for Treatment of Significant Saphenous Vein Graft Lesions
Study Overview
Status
Intervention / Treatment
Detailed Description
This is a phase IV, multi-center, single-arm, observational study evaluating the outcomes of native coronary artery PCI in patients presenting with severe SVG lesions.
Subjects will undergo clinically-indicated PCI of the native coronary artery that supplies the territory subtended by the diseased SVG at the discretion of the treating physicians.
The study team will screen and enroll patients after completion of index procedure.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
Michigan
-
Detroit, Michigan, United States, 48202
- Recruiting
- Henry Ford Health System
-
Contact:
- Khaldoon Alaswad, MD
-
-
Minnesota
-
Minneapolis, Minnesota, United States, 55407
- Recruiting
- Minneapolis Heart Institute Foundation
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age 18 years or older
- Presentation with a 50-99% de novo SVG lesion SVG lesion that is considered to cause clinical symptoms and is treated with percutaneous coronary intervention of the corresponding native coronary artery using a SYNERGY stent.
- Has provided informed consent and agrees to participate
Exclusion Criteria:
1. Known comorbidities/ conditions that, in the opinion of the investigator, limit life expectancy to less than 1 year
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Incidence of TVF in patients who present with SVG lesions and undergo PCI
Time Frame: 12 months
|
Investigating the incidence of target vessel failure in patients with saphenous vein graft lesions who undergo PCI of the native coronary artery. or coronary bypass surgery, and tamponade requiring pericardiocentesis or surgery. |
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Evaluate the incidence of various endpoints of patients undergoing PCI of the native coronary artery after SVG lesion development
Time Frame: 12 months
|
The following endpoints will be measured: procedural success and complications, all cause death and cardiac death, myocardial infarction during follow up, stent thrombosis, target lesion revascularization, target vessel revascularization, non-target vessel revascularization, the composite endpoint of any death, and myocardial infarction and target vessel revascularization (patient-oriented composite endpoint), the composite endpoint of cardiac death, target vessel myocardial infarction, and target lesion revascularization (device-oriented composite endpoint for target lesion failure), and stroke.
|
12 months
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- NASA
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Percutaneous Coronary Intervention
-
Ospedale della MisericordiaUnknownTo Achieve an Early Reendothelialization at the Expense of Low Restenosis: The EREMUS Study (EREMUS)Percutaneous Coronary Intervention | Angioplasty, Transluminal, Percutaneous CoronaryItaly
-
Asan Medical CenterLN RoboticsRecruitingPercutaneous Coronary InterventionKorea, Republic of
-
Portola PharmaceuticalsCompletedPercutaneous Coronary InterventionUnited States, Austria, Canada, Germany, Poland
-
Shiraz University of Medical SciencesBaqiyatallah university of medical sciencesCompletedPercutaneous Coronary Intervention
-
Corindus Inc.Completed
-
University of GroningenAbbottUnknownPercutaneous Coronary InterventionNetherlands
-
Stiftung Institut fuer HerzinfarktforschungCompletedPercutaneous Coronary InterventionGermany
-
Beijing Anzhen HospitalUnknownPercutaneous Coronary InterventionChina
-
SanofiCompletedPercutaneous Coronary Intervention
-
Shenyang Northern HospitalUnknownPercutaneous Coronary InterventionChina
Clinical Trials on Percutaneous coronary intervention of the native coronary artery with Synergy
-
Assistance Publique - Hôpitaux de ParisRecruiting
-
Royal Brompton & Harefield NHS Foundation TrustMedtronic; British Heart Foundation; Guidant Corporation; SchneiderCompletedCoronary Artery Disease
-
Ministry of Science and Higher Education, PolandUnknownIschemic Heart Disease | Myocardial Revascularization | Left Ventricular Ejection FractionPoland
-
Ministry of Science and Higher Education, PolandCompletedMyocardial Ischemia | Coronary Artery Stenosis | Myocardial RevascularizationUnited States, Poland
-
Shanghai Jiao Tong University School of MedicineUnknownHeart Failure Due to Coronary Artery DiseaseChina
-
Seung-Jung ParkCardioVascular Research Foundation, KoreaCompletedCoronary ArteriesKorea, Republic of
-
Aalborg University HospitalOulu University Hospital; Pauls Stradins Clinical University Hospital; Region...Terminated
-
Ajou University School of MedicineActive, not recruitingMyocardial Infarction | Obesity Associated DisorderKorea, Republic of
-
Seung-Jung ParkCardioVascular Research Foundation, KoreaTerminatedCoronary Occlusion | Coronary Stenosis | Coronary Artery StenosisKorea, Republic of
-
US Department of Veterans AffairsTerminated